SlovakiaTuberculosis profile
Population  2014 5.4 million
Estimates of TB burden * 2014 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) 0.025 (0.024–0.025) 0.45 (0.45–0.46)
Mortality (HIV+TB only) 0 (–) 0 (–)
Prevalence  (includes HIV+TB) 0.47 (0.19–0.85) 8.6 (3.6–16)
Incidence  (includes HIV+TB) 0.36 (0.32–0.41) 6.7 (5.9–7.6)
Incidence (HIV+TB only) <0.01 (<0.01–<0.01) 0.01 (0.01–0.01)
         
Case detection, all forms (%) 88 (78–100)    
Estimates of MDR-TB burden * 2014   New   Retreatment
% of TB cases with MDR-TB 0 (0–2.6) 3.7 (0.09–19)
MDR-TB cases among notified pulmonary
TB cases
0 (0–6) 2 (0–8)
TB case notifications 2014 New ** Relapse
Pulmonary, bacteriologically confirmed 155   21
Pulmonary, clinically diagnosed 77   5
Extrapulmonary 57   5
       
Total new and relapse 320    
Previously treated, excluding relapses 16    
Total cases notified 336    
Among 320 new and relapse cases:
44 (14%) cases aged under 15 years; male:female ratio: 1.4
Reported cases of RR-/MDR-TB 2014 New Retreatment Total **
Cases tested for RR-/MDR-TB 156 (101%) 38 (81%) 196
Laboratory-confirmed RR-/MDR-TB cases     7
Patients started on MDR-TB treatment ***     2
TB/HIV 2014 Number (%)
TB patients with known HIV status 308 (92)
HIV-positive TB patients 0 (0)
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT) 0  
HIV-positive TB patients on antiretroviral therapy (ART) 0  
HIV-positive people screened for TB 430  
HIV-positive people provided with IPT 0  
Treatment success rate and cohort size (%) Cohort
New and relapse cases registered in 2013 (94) 395
Previously treated cases, excluding relapse, registered in 2013 (67) 3
HIV-positive TB cases, all types, registered in 2013   0
RR-/MDR-TB cases started on second-line treatment in 2012   1
XDR-TB cases started on second-line treatment in 2012   0
Laboratories 2014  
Is second-line drug susceptibility testing available? Yes, in country
Financing TB control 2015  
National TB programme budget (US$ millions) <1
* Ranges represent uncertainty intervals
** Includes cases with unknown previous TB treatment history
*** Includes patients diagnosed before 2014 and patients who were not laboratory-confirmed as having
RR-/MDR-TB
***
(Rate per 100 000 population per year)
Mortality graph
   Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
   Prevalence

(Rate per 100 000 population per year)
Incidence graph
   Notified (new and relapse)   Incidence
   Incidence (HIV+TB only)

(Number of patients)
CPT ART graph
   HIV-positive TB patients
   on CPT   on ART

Treatment success rate (%)
tx success graph
   New   Retreatment
   New and relapse   Retreatment, excluding
relapse
   HIV-positive   RR-/MDR-TB   XDR-TB

 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 Generated: 2016-06-26 Data: www.who.int/tb/data